ONCLIVE NEWS NETWORK: ON LOCATION WILL BE LIVE AT ESMO THIS WEEK - STAY TUNED FOR MORE INFORMATION!

Dr. Benson on Extensive Biopsies for Low-Risk Prostate Cancer

Mitchell Benson, MD
Published: Monday, May 11, 2015



Mitchell Benson, MD, the Herbert and Florence Irving Professor at Columbia University Medical Center, New York-Presbyterian Hospital, discusses extensive biopsies in low-risk patients with prostate cancer.

According to a recent study, 30% of low-risk patients who underwent a more extensive biopsy were found to not be good candidates for ongoing active surveillance. Therefore, it is of a great value to confirm that these patients are indeed low-risk.

Benson explains that intermediate-risk patients are already known to not be ideal candidates for ongoing active surveillance. However, in this subset, physicians are assessing comorbidities and other reasons, based upon their life expectancy, for which active surveillance may be an appropriate strategy.


Mitchell Benson, MD, the Herbert and Florence Irving Professor at Columbia University Medical Center, New York-Presbyterian Hospital, discusses extensive biopsies in low-risk patients with prostate cancer.

According to a recent study, 30% of low-risk patients who underwent a more extensive biopsy were found to not be good candidates for ongoing active surveillance. Therefore, it is of a great value to confirm that these patients are indeed low-risk.

Benson explains that intermediate-risk patients are already known to not be ideal candidates for ongoing active surveillance. However, in this subset, physicians are assessing comorbidities and other reasons, based upon their life expectancy, for which active surveillance may be an appropriate strategy.



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
35th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® Clinical Vignette SeriesJan 31, 20192.0
Publication Bottom Border
Border Publication
x